Prudential Financial
ARIA

Prudential Financial’s Ariad Pharmaceuticals Inc ARIA Stock Holding History

Prudential Financial’s Portfolio ARIA Stock Details ARIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-20,175
Closed -$251K – 2431
2016
Q4 		$251K Buy
20,175
+100
+0.5% +$1.2K ﹤0.01% 2198
2016
Q3 		$275K Buy
20,075
+1,090
+6% +$10.9K ﹤0.01% 2157
2016
Q2 		$140K Buy
18,985
+2,100
+12% +$15.8K ﹤0.01% 2233
2016
Q1 		$108K Sell
16,885
-300
-2% -$1.68K ﹤0.01% 2247
2015
Q4 		$107K Sell
17,185
-200
-1% -$1.31K ﹤0.01% 2191
2015
Q3 		$102K Buy
17,385
+200
+1% +$1.54K ﹤0.01% 2174
2015
Q2 		$142K Sell
17,185
-200
-1% -$1.77K ﹤0.01% 2168
2015
Q1 		$143K Buy
17,385
+300
+2% +$2.22K ﹤0.01% 2163
2014
Q4 		$117K Sell
17,085
-5,700
-25% -$35.6K ﹤0.01% 2143
2014
Q3 		$123K Sell
22,785
-21,900
-49% -$128K ﹤0.01% 2160
2014
Q2 		$285K Buy
44,685
+29,800
+200% +$205K ﹤0.01% 2195
2014
Q1 		$120K Hold
14,885
– – ﹤0.01% 2207
2013
Q4 		$102K Sell
14,885
-800
-5% -$4.32K ﹤0.01% 2231
2013
Q3 		$289K Sell
15,685
-200
-1% -$3.88K ﹤0.01% 2089
2013
Q2 		$278K Buy
+15,885
New +$282K ﹤0.01% 2094

Other funds holding ARIA

FPF
FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Prudential Financial's ARIA Position: Q1 2017 in Review

Prudential Financial sold out of Ariad Pharmaceuticals Inc (ARIA) in Q1 2017, closing a stake of 20,175 shares — an estimated $251K sold.

Prudential Financial first reported a position in ARIA in Q2 2013 and held it in 15 quarters. The position peaked at $289K in Q3 2013. 1 fund tracked by Wall St. Rank holds ARIA as of Q1 2017.

  • Prudential Financial reported no remaining Ariad Pharmaceuticals Inc position as of Q1 2017 after selling out during the quarter.
  • Prudential Financial sold 20,175 Ariad Pharmaceuticals Inc shares in Q1 2017, an estimated $251K.
  • Prudential Financial first reported a position in Ariad Pharmaceuticals Inc in Q2 2013 and held it in 15 quarters.
  • Prudential Financial's Ariad Pharmaceuticals Inc position peaked at $289K in Q3 2013.
  • 1 fund tracked by Wall St. Rank held Ariad Pharmaceuticals Inc as of Q1 2017.

Based on Prudential Financial's 13F filing for Q1 2017, filed 10 May 2017.